Mrs Maggie Elizabeth Stadtlander, CRNA | |
2500 Belle Chasse Hwy, Terrytown, LA 70056-7127 | |
(504) 391-5157 | |
(504) 391-5633 |
Full Name | Mrs Maggie Elizabeth Stadtlander |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 3 Years |
Location | 2500 Belle Chasse Hwy, Terrytown, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194354134 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 220300 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
West Jefferson Medical Center | Marrero, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Childrens Hospital Anesthesia Corporation | 0446152862 | 221 |
News Archive
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.
The Chicago Teachers' Pension Fund (CTPF) received more than $585 million earlier today, completing the $612.5 million required contribution from the Chicago Board of Education (BOE) for the 2014 fiscal year.
An individual's reason for undergoing a medical intervention - be it to prevent or treat disease, earn money, or to have a child - may result in variations in the bodily experience of the patient, Yale researchers have found.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
› Verified 2 days ago
Entity Name | Ochsner Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.
The Chicago Teachers' Pension Fund (CTPF) received more than $585 million earlier today, completing the $612.5 million required contribution from the Chicago Board of Education (BOE) for the 2014 fiscal year.
An individual's reason for undergoing a medical intervention - be it to prevent or treat disease, earn money, or to have a child - may result in variations in the bodily experience of the patient, Yale researchers have found.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
› Verified 2 days ago
Entity Name | Childrens Hospital Anesthesia Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649362740 PECOS PAC ID: 0446152862 Enrollment ID: O20040124000258 |
News Archive
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.
The Chicago Teachers' Pension Fund (CTPF) received more than $585 million earlier today, completing the $612.5 million required contribution from the Chicago Board of Education (BOE) for the 2014 fiscal year.
An individual's reason for undergoing a medical intervention - be it to prevent or treat disease, earn money, or to have a child - may result in variations in the bodily experience of the patient, Yale researchers have found.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Maggie Elizabeth Stadtlander, CRNA 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Mrs Maggie Elizabeth Stadtlander, CRNA 2500 Belle Chasse Hwy, Terrytown, LA 70056-7127 Ph: (504) 391-5157 |
News Archive
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.
The Chicago Teachers' Pension Fund (CTPF) received more than $585 million earlier today, completing the $612.5 million required contribution from the Chicago Board of Education (BOE) for the 2014 fiscal year.
An individual's reason for undergoing a medical intervention - be it to prevent or treat disease, earn money, or to have a child - may result in variations in the bodily experience of the patient, Yale researchers have found.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed an asset purchase agreement with Nephromics LLC, which includes a patent license for exclusive rights to use PlGF for the diagnosis of pre-eclampsia or eclampsia. Clinical trials have shown that PlGF supports the diagnosis and risk prediction for preeclampsia.
A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.
› Verified 2 days ago
Kayla Briley Wheeler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5157 Fax: 504-391-5633 | |
John Paul Spera, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5157 | |
Charles Belair, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5157 | |
Jenny Dufrene, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5157 | |
Mr. Robert Lee Edwards, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-392-3131 |